Vector Laboratories’ blog provides a wealth of information on immunohistochemistry (IHC), immunofluorescence (IF), and related life science research topics.
NEWARK, Calif.July 15, 2025 The new kit combines Vector’s validated lectins with Navinci’s in situ PLA technology to gain insights beyond protein expression. Vector Laboratories, a leader in innovative proteomic and glycomic research solutions, and Navinci,... Read more
NEWARK, Calif.April 28, 2025 Leader in manufacturing reagents and critical components for biomedical research partners with spatial biology solutions company to support simultaneous detection of 10+ markers in a single tissue sample using off-the-shelf antibodies... Read more
NEWARK, Calif.February 24, 2025 Accomplished marketing leader to drive strategic growth and customer-first initiatives. Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage... Read more
NEWARK, Calif.February 20, 2025 Leader in manufacturing reagents and critical components for biomedical research to leverage Etcembly’s AI platform to optimize antibody engineering. Vector Laboratories, a manufacturing partner of reagents and critical components for the development... Read more
Protein detection and bioconjugation pioneer enhances portfolio in antibody reagents while growing its commercial footprint into the UK and EU. NEWARK, Calif.May 15, 2024 Vector Laboratories, a manufacturing partner of reagents and critical components for... Read more
Introducing innovative tools combining proteomics and glycomics within the spatial context, overcoming previous challenges and advancing the possibilities for biopharma discovery. NEWARK, Calif.January 30, 2024 Vector Laboratories, the pioneer of innovative proteomic and glycomic research... Read more
Acquisition expands customers’ ability to accelerate their advanced bioconjugate and payload delivery design innovation NEWARK, CalifJuly 17, 2023 Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, today announced the acquisition of Quanta BioDesign,... Read more
NEWARK, Calif. March 2, 2023 Acquisition contributes to long-term growth strategy of accelerating commercialization of innovative labeling and detection technologies Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, today announced the acquisitions... Read more
New parent company unites multiple antibody-centric brands to deliver unique antibody solutions Boston, MA. October 4, 2022. Absolute Biotech launched today as a unified company joining together leading antibody-centric brands from around the world. Absolute Biotech specializes... Read more
NEWARK, Calif.August 2, 2022 Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, announced today that it has achieved ISO 9001:2015 certification of its new facility in Newark, California. This designation, renewed in May... Read more
